vs
Side-by-side financial comparison of EPAM Systems (EPAM) and Solventum (SOLV). Click either name above to swap in a different company.
Solventum is the larger business by last-quarter revenue ($2.0B vs $1.4B, roughly 1.4× EPAM Systems). EPAM Systems runs the higher net margin — 7.8% vs 3.2%, a 4.6% gap on every dollar of revenue. On growth, EPAM Systems posted the faster year-over-year revenue change (12.8% vs -3.7%). EPAM Systems produced more free cash flow last quarter ($268.1M vs $32.0M). Over the past eight quarters, EPAM Systems's revenue compounded faster (9.9% CAGR vs -0.4%).
EPAM Systems, Inc. is an American company that specializes in software engineering services, digital platform engineering, and digital product design, operating out of Newtown, Pennsylvania. EPAM is a founding member of the MACH Alliance.
Solventum Corporation is an American health care company that was spun off from 3M on April 1, 2024.
EPAM vs SOLV — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $1.4B | $2.0B |
| Net Profit | $109.4M | $63.0M |
| Gross Margin | 30.1% | 51.4% |
| Operating Margin | 10.6% | 6.3% |
| Net Margin | 7.8% | 3.2% |
| Revenue YoY | 12.8% | -3.7% |
| Net Profit YoY | 5.9% | 103.2% |
| EPS (diluted) | $1.97 | $0.37 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $1.4B | $2.0B | ||
| Q3 25 | $1.4B | $2.1B | ||
| Q2 25 | $1.4B | $2.2B | ||
| Q1 25 | $1.3B | $2.1B | ||
| Q4 24 | $1.2B | $2.1B | ||
| Q3 24 | $1.2B | $2.1B | ||
| Q2 24 | $1.1B | $2.1B | ||
| Q1 24 | $1.2B | $2.0B |
| Q4 25 | $109.4M | $63.0M | ||
| Q3 25 | $106.8M | $1.3B | ||
| Q2 25 | $88.0M | $90.0M | ||
| Q1 25 | $73.5M | $137.0M | ||
| Q4 24 | $103.3M | $31.0M | ||
| Q3 24 | $136.3M | $122.0M | ||
| Q2 24 | $98.6M | $89.0M | ||
| Q1 24 | $116.2M | $237.0M |
| Q4 25 | 30.1% | 51.4% | ||
| Q3 25 | 29.5% | 54.2% | ||
| Q2 25 | 28.8% | 54.4% | ||
| Q1 25 | 26.9% | 53.8% | ||
| Q4 24 | 30.4% | 53.9% | ||
| Q3 24 | 34.6% | 56.0% | ||
| Q2 24 | 29.3% | 54.6% | ||
| Q1 24 | 28.4% | 58.1% |
| Q4 25 | 10.6% | 6.3% | ||
| Q3 25 | 10.4% | 80.6% | ||
| Q2 25 | 9.3% | 9.9% | ||
| Q1 25 | 7.6% | 7.3% | ||
| Q4 24 | 10.9% | 6.6% | ||
| Q3 24 | 15.2% | 13.2% | ||
| Q2 24 | 10.5% | 11.7% | ||
| Q1 24 | 9.5% | 18.9% |
| Q4 25 | 7.8% | 3.2% | ||
| Q3 25 | 7.7% | 60.4% | ||
| Q2 25 | 6.5% | 4.2% | ||
| Q1 25 | 5.6% | 6.6% | ||
| Q4 24 | 8.3% | 1.5% | ||
| Q3 24 | 11.7% | 5.9% | ||
| Q2 24 | 8.6% | 4.3% | ||
| Q1 24 | 10.0% | 11.8% |
| Q4 25 | $1.97 | $0.37 | ||
| Q3 25 | $1.91 | $7.22 | ||
| Q2 25 | $1.56 | $0.51 | ||
| Q1 25 | $1.28 | $0.78 | ||
| Q4 24 | $1.80 | $0.18 | ||
| Q3 24 | $2.37 | $0.70 | ||
| Q2 24 | $1.70 | $0.51 | ||
| Q1 24 | $1.97 | $1.37 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $1.3B | $878.0M |
| Total DebtLower is stronger | — | $5.0B |
| Stockholders' EquityBook value | $3.7B | $5.0B |
| Total Assets | $4.9B | $14.3B |
| Debt / EquityLower = less leverage | — | 1.00× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $1.3B | $878.0M | ||
| Q3 25 | $1.2B | $1.6B | ||
| Q2 25 | $1.0B | $492.0M | ||
| Q1 25 | $1.2B | $534.0M | ||
| Q4 24 | $1.3B | $762.0M | ||
| Q3 24 | $2.1B | $772.0M | ||
| Q2 24 | $1.8B | $897.0M | ||
| Q1 24 | $2.0B | $996.0M |
| Q4 25 | — | $5.0B | ||
| Q3 25 | — | $5.1B | ||
| Q2 25 | — | $7.8B | ||
| Q1 25 | — | $7.9B | ||
| Q4 24 | — | $8.0B | ||
| Q3 24 | — | $8.1B | ||
| Q2 24 | — | $8.3B | ||
| Q1 24 | — | $8.3B |
| Q4 25 | $3.7B | $5.0B | ||
| Q3 25 | $3.7B | $5.0B | ||
| Q2 25 | $3.7B | $3.6B | ||
| Q1 25 | $3.6B | $3.3B | ||
| Q4 24 | $3.6B | $3.0B | ||
| Q3 24 | $3.6B | $3.2B | ||
| Q2 24 | $3.4B | $2.9B | ||
| Q1 24 | $3.5B | $3.9B |
| Q4 25 | $4.9B | $14.3B | ||
| Q3 25 | $4.8B | $14.0B | ||
| Q2 25 | $4.7B | $15.1B | ||
| Q1 25 | $4.7B | $14.5B | ||
| Q4 24 | $4.8B | $14.5B | ||
| Q3 24 | $4.5B | $14.7B | ||
| Q2 24 | $4.2B | $14.6B | ||
| Q1 24 | $4.4B | $14.7B |
| Q4 25 | — | 1.00× | ||
| Q3 25 | — | 1.03× | ||
| Q2 25 | — | 2.14× | ||
| Q1 25 | — | 2.43× | ||
| Q4 24 | — | 2.71× | ||
| Q3 24 | — | 2.54× | ||
| Q2 24 | — | 2.90× | ||
| Q1 24 | — | 2.16× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $282.9M | $95.0M |
| Free Cash FlowOCF − Capex | $268.1M | $32.0M |
| FCF MarginFCF / Revenue | 19.0% | 1.6% |
| Capex IntensityCapex / Revenue | 1.1% | 3.2% |
| Cash ConversionOCF / Net Profit | 2.59× | 1.51× |
| TTM Free Cash FlowTrailing 4 quarters | $612.7M | $-10.0M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $282.9M | $95.0M | ||
| Q3 25 | $294.7M | $76.0M | ||
| Q2 25 | $53.2M | $169.0M | ||
| Q1 25 | $24.2M | $29.0M | ||
| Q4 24 | $130.3M | $219.0M | ||
| Q3 24 | $242.0M | $169.0M | ||
| Q2 24 | $57.0M | $355.0M | ||
| Q1 24 | $129.9M | $442.0M |
| Q4 25 | $268.1M | $32.0M | ||
| Q3 25 | $286.4M | $-21.0M | ||
| Q2 25 | $43.4M | $59.0M | ||
| Q1 25 | $14.8M | $-80.0M | ||
| Q4 24 | $114.5M | $92.0M | ||
| Q3 24 | $237.0M | $76.0M | ||
| Q2 24 | $52.3M | $297.0M | ||
| Q1 24 | $123.2M | $340.0M |
| Q4 25 | 19.0% | 1.6% | ||
| Q3 25 | 20.5% | -1.0% | ||
| Q2 25 | 3.2% | 2.7% | ||
| Q1 25 | 1.1% | -3.9% | ||
| Q4 24 | 9.2% | 4.4% | ||
| Q3 24 | 20.3% | 3.7% | ||
| Q2 24 | 4.6% | 14.3% | ||
| Q1 24 | 10.6% | 16.9% |
| Q4 25 | 1.1% | 3.2% | ||
| Q3 25 | 0.6% | 4.6% | ||
| Q2 25 | 0.7% | 5.1% | ||
| Q1 25 | 0.7% | 5.3% | ||
| Q4 24 | 1.3% | 6.1% | ||
| Q3 24 | 0.4% | 4.5% | ||
| Q2 24 | 0.4% | 2.8% | ||
| Q1 24 | 0.6% | 5.1% |
| Q4 25 | 2.59× | 1.51× | ||
| Q3 25 | 2.76× | 0.06× | ||
| Q2 25 | 0.60× | 1.88× | ||
| Q1 25 | 0.33× | 0.21× | ||
| Q4 24 | 1.26× | 7.06× | ||
| Q3 24 | 1.77× | 1.39× | ||
| Q2 24 | 0.58× | 3.99× | ||
| Q1 24 | 1.12× | 1.86× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
EPAM
Segment breakdown not available.
SOLV
| Infection Prevention And Surgical Solutions | $752.0M | 38% |
| Cost Of Software And Rentals | $508.0M | 25% |
| Health Information Systems Segment | $347.0M | 17% |
| Dental Solutions Segment | $343.0M | 17% |
| Related Party | $14.0M | 1% |
